These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8055914)

  • 1. The calpain cleavage sites in the epidermal growth factor receptor kinase domain.
    Gregoriou M; Willis AC; Pearson MA; Crawford C
    Eur J Biochem; 1994 Jul; 223(2):455-64. PubMed ID: 8055914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
    Lombardo CR; Consler TG; Kassel DB
    Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility.
    Stabach PR; Cianci CD; Glantz SB; Zhang Z; Morrow JS
    Biochemistry; 1997 Jan; 36(1):57-65. PubMed ID: 8993318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the active site of m-calpain and the interaction with calpastatin.
    Crawford C; Brown NR; Willis AC
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):135-42. PubMed ID: 8250833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function.
    Gullick WJ; Downward J; Waterfield MD
    EMBO J; 1985 Nov; 4(11):2869-77. PubMed ID: 2415353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant form of the catalytic subunit of phosphorylase kinase that is soluble, monomeric, and includes key C-terminal residues.
    Pete MJ; Liao CX; Bartleson C; Graves DJ
    Arch Biochem Biophys; 1999 Jul; 367(1):104-14. PubMed ID: 10375405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells.
    Glantz SB; Cianci CD; Iyer R; Pradhan D; Wang KK; Morrow JS
    Biochemistry; 2007 Jan; 46(2):502-13. PubMed ID: 17209560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of catalytic domains and phosphorylation sites in the multifunctional pyrimidine-biosynthetic protein CAD.
    Carrey EA; Hardie DG
    Eur J Biochem; 1988 Feb; 171(3):583-8. PubMed ID: 3345746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain cleavage of integrin beta cytoplasmic domains.
    Pfaff M; Du X; Ginsberg MH
    FEBS Lett; 1999 Oct; 460(1):17-22. PubMed ID: 10571053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different forms of the epidermal growth factor receptor kinase have different autophosphorylation sites.
    Gates RE; King LE
    Biochemistry; 1985 Sep; 24(19):5209-15. PubMed ID: 3000427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of native p94, a muscle-specific calpain, and characterization of its autolysis.
    Kinbara K; Ishiura S; Tomioka S; Sorimachi H; Jeong SY; Amano S; Kawasaki H; Kolmerer B; Kimura S; Labeit S; Suzuki K
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):589-96. PubMed ID: 9794799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro generation of an active calmodulin-independent phosphodiesterase from brain calmodulin-dependent phosphodiesterase (PDE1A2) by m-calpain.
    Kakkar R; Raju RV; Sharma RK
    Arch Biochem Biophys; 1998 Oct; 358(2):320-8. PubMed ID: 9784246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of a cAMP-dependent protein kinase phosphorylation site in the C-terminal region of human endothelial actin-binding protein.
    Jay D; García EJ; Lara JE; Medina MA; de la Luz Ibarra M
    Arch Biochem Biophys; 2000 May; 377(1):80-4. PubMed ID: 10775444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure--function relationship of the human erythrocyte plasma membrane Ca(2+)-ATPase revealed by V8 protease treatment.
    Wang KK; Roufogalis BD; Kuo TH
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):537-44. PubMed ID: 1835379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncation of human dopamine transporter by protease calpain.
    Franekova V; Baliova M; Jursky F
    Neurochem Int; 2008 Jun; 52(8):1436-41. PubMed ID: 18468730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of the gap junction protein connexin50 in the ocular lens is accomplished by calpain.
    Lin JS; Fitzgerald S; Dong Y; Knight C; Donaldson P; Kistler J
    Eur J Cell Biol; 1997 Jun; 73(2):141-9. PubMed ID: 9208227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of autolysis on the structure of chicken calpain II.
    Crawford C; Willis AC; Gagnon J
    Biochem J; 1987 Dec; 248(2):579-88. PubMed ID: 2829834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited proteolysis of tyrosine hydroxylase by Ca(2+)-activated neutral protease (calpain).
    Kiuchi K; Kiuchi K; Titani K; Fujita K; Suzuki K; Nagatsu T
    Biochemistry; 1991 Oct; 30(43):10416-9. PubMed ID: 1681901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calpain is involved in C-terminal truncation of human aggrecan.
    Struglics A; Hansson M
    Biochem J; 2010 Sep; 430(3):531-8. PubMed ID: 20618160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.